Shafer Commission

Last updated
Shafer Commission
TypeCommission
Chair
Raymond P. Shafer

The Shafer Commission, formally known as the National Commission on Marihuana and Drug Abuse, was appointed by U.S. President Richard Nixon in the early 1970s. Its chairman was former Pennsylvania Governor Raymond P. Shafer. The commission issued a report on its findings in 1972 that called for the decriminalization of marijuana possession in the United States. [1] The report was ignored by the White House, but is an important document against prohibition. [2]

Contents

While the Controlled Substances Act was being drafted in a House committee in 1970, Assistant Secretary of Health Roger O. Egeberg had recommended that marijuana temporarily be placed in Schedule I, the most restrictive category of drugs, pending the Commission's report. On March 22, 1972, the Commission's chairman, Raymond P. Shafer, presented a report to Congress and the public entitled "Marihuana, a Signal of Misunderstanding," which favored ending marijuana prohibition and adopting other methods to discourage use. The report was republished as a Signet Books New American Library paperback in 1972. [3]

The Commission's report said that while public sentiment tended to view marijuana users as dangerous, they actually found users to be more timid, drowsy and passive. It concluded that cannabis did not cause widespread danger to society. It recommended using social measures other than criminalization to discourage use. It compared the situation of cannabis to that of alcohol. [4]

The Commission's proposed decriminalization of marijuana possession was opposed, in 1974, by the recommendations of a congressional subcommittee chaired by Senator James Eastland. [5]

The Nixon administration did not implement the recommendations from the National Commission on Marihuana and Drug Abuse. [2] However, the report has frequently been cited by individuals supporting removal of cannabis from Schedule I of the Controlled Substances Act. [6]

Members

Related Research Articles

The National Organization for the Reform of Marijuana Laws is a social welfare organization based in Washington, D.C., that advocates for the reform of marijuana laws in the United States regarding both medical and non-medical use. According to their website, NORML supports "the removal of all penalties for the private possession and responsible use of marijuana by adults, including cultivation for personal use, and casual nonprofit transfers of small amounts" and advocates for "the creation of a legal and regulatory framework for marijuana's production and retail sale to adults". NORML also has a sister organization, NORML Foundation, that focuses on educational efforts and providing legal assistance and support to people affected negatively by current marijuana laws. NORML maintains chapters in a number of US states as well as outside the US in countries such as Canada, France, New Zealand, and South Africa.

<span class="mw-page-title-main">LaGuardia Committee</span> Study into the effects of smoking cannabis

The LaGuardia Committee was the first in-depth study into the effects of smoking cannabis in the United States. An earlier study, the Indian Hemp Drugs Commission, was conducted by the colonial authorities in British India in 1893–94. The reports systematically contradicted claims made by the U.S. Treasury Department that smoking marijuana results in insanity, deteriorates physical and mental health, assists in criminal behavior and juvenile delinquency, is physically addictive, and is a "gateway" drug to more dangerous drugs.

<span class="mw-page-title-main">Legalization of non-medical cannabis in the United States</span> Legalization of marijuana in the United States

In the United States, the non-medical use of cannabis is legalized in 21 states and decriminalized in 10 states, as of January 2023. Decriminalization refers to a policy of reduced penalties for cannabis offenses, typically involving a civil penalty for possessing small amounts, instead of criminal prosecution or the threat of arrest. In jurisdictions without penalty the policy is referred to as legalization, although the term decriminalization is sometimes used for this purpose as well.

<span class="mw-page-title-main">Legal history of cannabis in the United States</span>

In the United States, increased restrictions and labeling of cannabis as a poison began in many states from 1906 onward, and outright prohibitions began in the 1920s. By the mid-1930s cannabis was regulated as a drug in every state, including 35 states that adopted the Uniform State Narcotic Drug Act. The first national regulation was the Marihuana Tax Act of 1937.

<span class="mw-page-title-main">Drug liberalization</span> Process of reducing drug prohibition laws

Drug liberalization is a drug policy process of decriminalizing or legalizing the use or sale of prohibited drugs. Variations of drug liberalization include: drug legalization, drug re-legalization and drug decriminalization. Proponents of drug liberalization may favor a regulatory regime for the production, marketing, and distribution of some or all currently illegal drugs in a manner analogous to that for alcohol, caffeine and tobacco.

The Personal Use of Marijuana by Responsible Adults Act of 2008 was a bill in the United States House of Representatives introduced by Barney Frank (D-MA) in the 110th congress on April 17, 2008 as H.R. 5843. The bill had a total of 8 cosponsors. Its passage would have eliminated federal criminal penalties for possession of up to 100 grams (3.5 oz) and nonprofit transfer of up to an ounce of cannabis under the Controlled Substances Act. It does not change the regulation on the manufacturing or the sale of cannabis. It is the first bill of its kind to be introduced at the federal level in the U.S. since 1984.

<span class="mw-page-title-main">2008 Massachusetts Question 2</span> Ballot measure in Massachusetts

The Sensible Marijuana Policy Initiative, also known as Massachusetts Ballot Question 2, was an initiated state statute that replaced prior criminal penalties with new civil penalties on adults possessing an ounce or less of marijuana. The initiative appeared on the November 4, 2008, ballot in Massachusetts.

<span class="mw-page-title-main">Medical cannabis in the United States</span> Use of cannabis for medical purposes in the United States

In the United States, the use of cannabis for medical purposes is legal in 38 states, four out of five permanently inhabited U.S. territories, and the District of Columbia, as of March 2023. Ten other states have more restrictive laws limiting THC content, for the purpose of allowing access to products that are rich in cannabidiol (CBD), a non-psychoactive component of cannabis. There is significant variation in medical cannabis laws from state to state, including how it is produced and distributed, how it can be consumed, and what medical conditions it can be used for.

This is a history of drug prohibition in the United States.

<span class="mw-page-title-main">Legality of cannabis by U.S. jurisdiction</span> Cannabis laws by state and territory

In the United States, the use and possession of cannabis is illegal under federal law for any purpose by way of the Controlled Substances Act of 1970 (CSA). Under the CSA, cannabis is classified as a Schedule I substance, determined to have a high potential for abuse and no accepted medical use. Despite this, most states have legalized either or both the medical and recreational use of cannabis.

Proposition 19, also known as the California Marijuana Initiative (CMI), was a ballot initiative on the November 7, 1972 California statewide ballot. This was the first attempt to legalize marijuana by ballot measure in the history of the United States. If it had passed, the measure would have removed penalties in the State of California for persons 18 years of age or older for using, possessing, growing, processing, or transporting marijuana for personal use. The California Marijuana Initiative's organizers coordinated a huge grassroots organizing drive to place the measure on the ballot. The initiative qualified for the November statewide ballot in June 1972. The initiative was defeated by the voters with 66.5% No votes to 33.5% Yes votes.

Henry Brill was an American psychiatrist and educator. A native of Bridgeport, Connecticut, he earned both his undergraduate and medical degrees from Yale University. After receiving his M.D. in 1932, he began a career in the New York state psychiatric system, culminating in the directorship of Pilgrim Psychiatric Center in Brentwood, NY from 1958 to 1976. At its height in the mid-1950s, Pilgrim was the largest mental institution in the world, with a census of 13,875 patients. Brill also served as Deputy Commissioner of the New York State Department of Mental Hygiene from 1959 to 1964.

<span class="mw-page-title-main">Timeline of cannabis laws in the United States</span> Historical list in chronological order of U.S. cannabis law

The legal history of cannabis in the United States began with state-level prohibition in the early 20th century, with the first major federal limitations occurring in 1937. Starting with Oregon in 1973, individual states began to liberalize cannabis laws through decriminalization. In 1996, California became the first state to legalize medical cannabis, sparking a trend that spread to a majority of states by 2016. In 2012, Washington and Colorado became the first states to legalize cannabis for recreational use.

<span class="mw-page-title-main">Cannabis in New Mexico</span> Overview of the use and culture of cannabis in New Mexico, U.S.

Cannabis in New Mexico is legal for recreational use as of June 29, 2021. A bill to legalize recreational use – House Bill 2, the Cannabis Regulation Act – was signed by Governor Michelle Lujan Grisham on April 12, 2021. The first licensed sales of recreational cannabis began on April 1, 2022.

<span class="mw-page-title-main">Glossary of cannabis terms</span>

Terms related to cannabis include:

Cannabis in Mali is illegal.

During the administration of American President Jimmy Carter (1977–1981), the United States gave further consideration to the decriminalization of cannabis (marijuana), with the support of the president. However, law enforcement, conservative politicians, and grassroots parents' groups opposed this measure. The net result of the Carter administration was the continuation of the War on Drugs and restrictions on cannabis, while at the same time cannabis consumption in the United States reached historically high levels.

During the administration of American President Lyndon B. Johnson (1963–1969), the government made moves to reconsider cannabis law enforcement in the nation, including a more treatment-based approach to drug use. However, Johnson was saddled with controversies regarding the Vietnam War and internal national tensions, and was not able to make major changes to cannabis policy before declining to run for a second term in 1968. During the Johnson administration, cannabis usage was an issue of concern both in the youth counterculture as well as among American troops serving in the Vietnam War.

During the administration of American President Richard Nixon (1969–1974), the United States turned to increasingly harsh measures against cannabis use, and a step away from proposals to decriminalize or legalize the drug. The administration began the War on Drugs, with Nixon in 1971 naming drug abuse as "public enemy number one in the United States."

References

  1. United States National Commission on Marihuana and Drug Abuse (1972). Marihuana: a symbol of misunderstanding. Washington, DC: US Government Printing Office. OL   17346935W.
  2. 1 2 Graham, Fred P. (February 13, 1972). "National Commission to Propose Legal Private Use of Marijuana". The New York Times. Retrieved March 15, 2022. President Nixon said, "Even if the commission does recommend that it be legalized, I will not follow that recommendation."
  3. Clayton, Richard R; Sloboda, Zili; Page, Bryan (Winter 2009), "Reflections on 40 Years of Drug Abuse Research: Changes in the Epidemiology of Drug Abuse", Journal of Drug Issues , 39 (1): 41–55, doi:10.1177/002204260903900105, S2CID   70592481
  4. "Drugs And Social Responsibility". Druglibrary.org. Retrieved April 20, 2011.
  5. Marihuana-hashish epidemic and its impact on United States security: hearings before the Subcommittee to Investigate the Administration of the Internal Security Act and Other Internal Security Laws of the Committee on the Judiciary, United States Senate, Ninety-third Congress, second session [-Ninety-fourth Congress, first session] .. ,1974
  6. "Nixon Commission Report Advising Decriminalization of Marijuana Celebrates 30th Anniversary". NORML. Archived from the original on September 29, 2011. Retrieved April 20, 2011.
  7. Drug Use in America: Problem in Perspective: Second Report . Ardent Media. 1973. ISBN   978-0-8422-7239-1.

Further reading